LITS

Lite Strategy, Inc.
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$33.05M
P/E Ratio
EPS
$-2.08
Beta
0.05
52W High
$9.00
52W Low
$0.69
50-Day MA
$1.00
200-Day MA
$1.44
Dividend Yield
Profit Margin
0.00%
Forward P/E
4.62
PEG Ratio
2.22

About Lite Strategy, Inc.

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.

Official WebsiteUSAFY End: June

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)$-1.97M
EBITDA$-17.13M
Operating Margin0.00%
Return on Equity-159.30%
Return on Assets-27.70%
Revenue/Share (TTM)$0.00
Book Value$1.62
Price-to-Book0.58
Price-to-Sales (TTM)0.30
EV/Revenue0.812
EV/EBITDA2.38
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$34.03M
Float$26.40M
% Insiders11.96%
% Institutions17.32%

Historical Volatility

HV 10-Day
68.55%
HV 20-Day
86.78%
HV 30-Day
100.48%
HV 60-Day
79.02%
HV Rank
65.1%

Volatility is currently contracting

Latest News

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) ("Lite Strategy" or the "Company"), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced its participation in a featured panel at the Litecoin Foundation Summit, taking place June 22-23, 2026 at the Tobacco Theatre in Amsterdam, Netherlands. The Litecoin Foundation Summit is the flagship annual gathering of the Litecoin ecosystem, held this year in collaboration with Dutch Blockchain Week.

GlobeNewsWire6/19/2026Neutral
Lite Strategy Reports Fiscal 2026 Third Quarter Results

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced financial results for the fiscal 2026 third quarter ended March 31, 2026. Business and Financial Highlights: Active Treasury Management: Successfully continued the Company's covered call option program, generating $0.7 million in net proceeds since October 2025 and further demonstrating Lite Strategy's ability to transform its LTC holdings into a yield-generating reserve asset and differentiate itself from passive investment vehicles.

GlobeNewsWire5/13/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026